Gestão de Antimicrobianos
Revisão clínica | Tratamento da pneumonia em pacientes criticamente doentes.
7 Dez, 2021 | 11:33hManagement of pneumonia in critically ill patients – The BMJ
Estudo randomizado | Maribavir para infecções por citomegalovírus refratárias com ou sem resistência pós-transplante.
7 Dez, 2021 | 11:29hRevisão com imagens | Distúrbios espinais mimetizando infecção.
6 Dez, 2021 | 16:04hSpinal disorders mimicking infection – Insights into Imaging
Revisão | Intervenções para otimizar a gestão de antibióticos.
3 Dez, 2021 | 11:01hRevisão | Infecção fúngica invasiva associada à COVID-19.
24 Nov, 2021 | 11:34hCOVID-19-associated Invasive Fungal Infection – Open Forum Infectious Diseases
Conteúdos relacionados:
Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis
Bacterial and fungal superinfections in critically ill patients with COVID-19
Invasive Fungal Disease complicating COVID-19: when it rains it pours
A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients
Comentário no Twitter
A new article in OFID reviews COVID-19-associated fungal infections and addresses gaps in knowledge relating to the epidemiology, diagnosis and management of these infections: https://t.co/JIkkW70zHI#IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @jobadd @DrPappasID pic.twitter.com/bPmFdKkjmb
— IDSA (@IDSAInfo) November 21, 2021
Diretriz IDSA sobre o tratamento de infecções por Gram-negativos resistentes a antibióticos.
23 Nov, 2021 | 15:46h
Comentário no Twitter
IDSA has released NEW guidance on treating infections caused by three of the most common drug-resistant pathogens:
• AmpC-E
• CRAB
• S. maltophiliaGuidelines: https://t.co/gjxEZcxtmy
Press release: https://t.co/ulorKCmvQ4#IDSAGuidelines #WAAW21 pic.twitter.com/Wy7uBaq2DN— IDSA (@IDSAInfo) November 22, 2021
Consciência sobre antibióticos: uma visão geral de evidências Cochrane.
23 Nov, 2021 | 15:37hAntibiotic Awareness: a round-up of Cochrane evidence – Cochrane Library
Comentário no Twitter
https://t.co/oVkKaj433K@CochraneUK – excellent resources and collection of antibiotic evidence review. #tldr
Azithro doesn’t work for COVID; procalcitonin reduces antibiotic use effectively; short course durations have similar outcomes to long; & so much more— Susan Hopkins (@SMHopkins) November 21, 2021
Atualizações recentes sobre a gestão de antibióticos para antibioticoterapia parenteral ambulatorial.
23 Nov, 2021 | 15:31hM-A | Ferro por via intravenosa está associado com risco aumentado de infecção em comparação com ferro por via oral ou não reposição, o que deve ser equilibrado com os benefícios potenciais da redução na necessidade de transfusão sanguínea.
19 Nov, 2021 | 12:58hComentário convidado: Intravenous Iron and Infection Risk—Still an Unanswered Question – JAMA Network Open
Comentário no Twitter
In this systematic review and meta-analysis, administration of intravenous iron was associated with an increased risk of infection. This risk must be balanced with the potential benefits of treating anemia and reducing blood transfusion requirements. https://t.co/XkNJKCk7M7
— JAMA Network Open (@JAMANetworkOpen) November 12, 2021
Controle de infecção na UTI: diretrizes de consenso de especialistas para SARS-CoV-2 utilizando o método Delphi.
12 Nov, 2021 | 13:49h
Comentário da autora no Twitter (fio – clique para saber mais)
Honoured to lead this Delphi on Infection Control in ICU for SARS-CoV-2 with global experts https://t.co/39NTHgfyZR @Drnasap @ElieAzoulay5 @jigidivatia @AlhazzaniW @NaomiHammond @criticcaredoc @YaseenarabiYa @Laura_Evans_206 @FlaviaSepsis @AndersPerner @jlvincen @TheLancetInfDis pic.twitter.com/RWw6vXcHb0
— Sheila Myatra (@SheilaMyatra) November 11, 2021


